GliaCure Secures $5,800,000 Series B Funding Round

  • Feed Type
  • Date
    8/5/2014
  • Company Name
    GliaCure
  • Mailing Address
    234 Causeway St. Boston, MA 02114 USA
  • Company Description
    GliaCure is focused on the development of novel therapies for neurological and neuropsychiatric disorders based on glia targets.
  • Website
    http://www.gliacure.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $5,800,000
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor

By posting a comment, you agree to our terms and conditions.